NUTRITIONAL DEFICIENCY AS A PATHOGENIC FACTOR IN FUNCTIONAL AND METABOLIC DISORDERS IN CHILDREN RECEIVING STANDARD CHEMOTHERAPY AFTER SURGICAL TREATMENT OF BRAIN MEDULLOBLASTOMA
Abstract
About the Authors
Y. A. KorchaginaRussian Federation
V. T. Dolgikh
Russian Federation
O. V. Korpacheva
Russian Federation
References
1. Hinkes B. G., Hoff K. von, Deinlein F. et al. Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91 // J Neurooncol. 2007. Vol. 81. P. 217-223.
2. Tompson M., Fuller C., Hogg T. et al. Genomic indentifiesmedulloblastoma subgroups that are enriched for specific genetic alterations // J Clin Onkol. 2006. Vol. 24. P. 1924-1932.
3. Шондус Д. Х., Щербенко О. И. Медуллобластома у детей. Клиника, диагностика, лечение, нерешенные проблемы // Вестник РНЦРР. 2013. № 3. Т.13. С. 1-46.
4. Slampa P., Zitterbart K., Dusek L. et al. Craniospinal irradiation of medulloblastoma in the supine position // Rep Pract Oncol Radiother. 2006. Vol. 11. № 6. P. 265-272.
5. Лукач В. Н., Орлов Ю. П., Долгих В. Т. и др. Обмен железа и его роль при травматической болезни // Анестезиология и реаниматология. 2014. № 1. С. 78-81.
6. Jones B., Wilson P., Nagano A. et al. Dillemas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medullablastoma // Br J Radiol. 2012. Vol. 85. № 10. P. 912-918.
7. Yang Z. J., Ellis T., Markant S. L. et al. Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells // Cancer Cell. 2008. № 14. P. 135-145.
8. Howell R. M., Giebel A., Koontz-Raisig W. et al. Comparison of therapeutic dosimetric data from passivly scattered proton craniospinal irradiation for medulloblastoma // Radiat Оncol. 2012. № 7. Vol. 24. P. 116-122.
9. Петри А., Сэбин К. Наглядная статистика в медицине. М. : ГЭОТАР-МЕД, 2003. 144 с.
10. Долгих В. Т. Патофизиология обмена веществ. Омск : ОГМА, 2013. 152 с.
Review
For citations:
Korchagina Y.A., Dolgikh V.T., Korpacheva O.V. NUTRITIONAL DEFICIENCY AS A PATHOGENIC FACTOR IN FUNCTIONAL AND METABOLIC DISORDERS IN CHILDREN RECEIVING STANDARD CHEMOTHERAPY AFTER SURGICAL TREATMENT OF BRAIN MEDULLOBLASTOMA. Vestnik SurGU. Meditsina. 2016;(4 (30)):45-50. (In Russ.)